2011 UNC Lineberger-CFAR AIDS Malignancy Retreat
|This retreat is part of the new UNC Global Oncology Program headed by Dr. Damania. The keynote speaker for the 2011 symposium is Dr. Robert Yarchoan, Director of the Office of HIV and AIDS Malignancy at the National Cancer Institute (NCI).|
It is estimated that there are over one million people living with HIV/AIDS in the United States today. With the advent of HAART, HIV-infected individuals are living longer and are therefore at a higher risk for developing AIDS-related malignancies. Cancers in the context of HIV infection tend to be more aggressive and/or remain refractory to standard therapies. Since 2008, the UNC LCCC, in conjunction with the UNC CFAR, has received supplemental funding from NCI/NIH to promote basic and translational pilot research projects on HIV-associated malignancies. In 2008, a LCCC AIDS-Associated Malignancy Group was formed and the group is headed by LCCC and CFAR member, Dr. Damania. In 2011, this group became part of the new UNC Global Oncology Program headed by Dr. Damania.
One of the NCI's global cancer portfolio focus areas is a particular strength at UNC infectious agents that are associated with the development of cancer. The focus of this retreat is to exchange information on different aspects of cancers that develop in HIV-infected individuals and to present research currently being conducted at UNC on AIDS-associated malignancies. A tentative program is listed below.